Showing 10,941 - 10,960 results of 23,167 for search '(( 2 step decrease ) OR ( 100 ((((mean decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.11s Refine Results
  1. 10941

    File S1 - Histone Deacetylase 1 and p300 Can Directly Associate with Chromatin and Compete for Binding in a Mutually Exclusive Manner by Xuehui Li (508048)

    Published 2014
    “…The glutathione sepharose immobilized GST-histone H3 protein was incubated with recombinant flag tagged HDAC1 with or without the presence of 100 nM or 300 nM TSA in a pull down assay. Histone H3 associated HDAC1 was detected by Western blotting with an anti-Flag antibody. …”
  2. 10942

    Lithium Borate Containing Bifunctional Binder To Address Both Ion Transporting and Polysulfide Trapping for High-Performance Li–S Batteries by Lei Zhong (192135)

    Published 2019
    “…A slightly cross-linked lithium borate containing single ion-conducting polymer (LBSIP) as a bifunctional binder for lithium sulfur batteries is designed and fabricated via a one-step thiol–ene click reaction. …”
  3. 10943

    Lithium Borate Containing Bifunctional Binder To Address Both Ion Transporting and Polysulfide Trapping for High-Performance Li–S Batteries by Lei Zhong (192135)

    Published 2019
    “…A slightly cross-linked lithium borate containing single ion-conducting polymer (LBSIP) as a bifunctional binder for lithium sulfur batteries is designed and fabricated via a one-step thiol–ene click reaction. …”
  4. 10944

    Lithium Borate Containing Bifunctional Binder To Address Both Ion Transporting and Polysulfide Trapping for High-Performance Li–S Batteries by Lei Zhong (192135)

    Published 2019
    “…A slightly cross-linked lithium borate containing single ion-conducting polymer (LBSIP) as a bifunctional binder for lithium sulfur batteries is designed and fabricated via a one-step thiol–ene click reaction. …”
  5. 10945

    A Personalized short-time Immunotherapy with Subcutaneous very low-dose Il-2 plus the Pineal Hormone Melatonin in advanced cancer patients with Persistent Lymphocytopenia by Paolo Lissoni (10019792)

    Published 2021
    “…Finally, it is known that lymphocytopenia may predict a negative prognosis in the advanced neoplasms, and a more negative significance is played by the occurrence of abnormally low values of lymphocyte-to-monocyte ratio (LMR), whose decline could depend on both lymphocyte decrease and monocyte increase. …”
  6. 10946
  7. 10947

    Data_Sheet_1_Efficacy of cranial electrotherapy stimulation in patients with burning mouth syndrome: a randomized, controlled, double-blind pilot study.docx by Annalena Palmer (17963963)

    Published 2024
    “…With the applied cutoff of 30% pain reduction within the stimulation period, both the active and sham groups had 36% responders (n = 4) (Fisher’s exact test, p = 1.00). In both groups (active stimulation and sham group), a significant decrease in the intensity of pain, somatic symptoms and an improvement in sleep quality over the study period was observed. …”
  8. 10948

    Supplementary Material for: Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity by Janssens A. (4152718)

    Published 2015
    “…From week 8, median platelet counts were >100 × 10<sup>9</sup>/l; 47% of the patients received rescue medications (the use decreased over time). …”
  9. 10949

    Image 1_The impact of the COVID-19 pandemic on the global burden of type 2 diabetes: a study based on GBD 2021 data.jpeg by Xiaoqin Chen (297788)

    Published 2025
    “…However, incorporating post-pandemic data (up to 2021) increased the projected 2030 prevalence to 10694.79 per 100,000, indicating a rise of 326.56 per 100,000 attributed to the pandemic’s impact. …”
  10. 10950

    Table 1_The impact of the COVID-19 pandemic on the global burden of type 2 diabetes: a study based on GBD 2021 data.docx by Xiaoqin Chen (297788)

    Published 2025
    “…However, incorporating post-pandemic data (up to 2021) increased the projected 2030 prevalence to 10694.79 per 100,000, indicating a rise of 326.56 per 100,000 attributed to the pandemic’s impact. …”
  11. 10951

    Supplementary Material for: Non-Melanoma Skin Cancer Distribution in the Russian Federation by Muntyanu A. (8936897)

    Published 2020
    “…The overall age-standardized incidence and mortality rates were 29.64/100,000 and 0.70/100,000, respectively. There was a consistent increase in age-standardized incidence rates over the study period, with a decreasing mortality rate. …”
  12. 10952

    Effects of antioxidant-rich <i>foods</i> on altitude-induced oxidative stress and inflammation in elite endurance athletes: A randomized controlled trial by Anu Elisa Koivisto (6837080)

    Published 2019
    “…The cytokine response to a stress-test (VO<sub>2max</sub> ramp test or 100 m swimming) was assessed at pre- and post-altitude.…”
  13. 10953

    A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants by Muhammed O. Afolabi (476516)

    Published 2013
    “…<div><p>Background</p><p>A vaccine to decrease transmission of human immunodeficiency virus type 1 (HIV-1) during breast-feeding would complement efforts to eliminate infant HIV-1 infection by antiretroviral therapy. …”
  14. 10954

    Synthesis, Structure, and Activity of Enhanced Initiators for Olefin Metathesis by Jennifer A. Love (1393678)

    Published 2003
    “…A series of ruthenium olefin metathesis catalysts of the general structure (H<sub>2</sub>IMes)(PR<sub>3</sub>)(Cl)<sub>2</sub>RuCHPh (H<sub>2</sub>IMes = 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene) have been prepared; these complexes are readily accessible in two steps from commercially available (H<sub>2</sub>IMes)(PCy<sub>3</sub>)(Cl)<sub>2</sub>RuCHPh. …”
  15. 10955

    CD8<sup>+</sup> T cells are not regulated by a PD-1-dependent mechanism in chronic <i>T</i>. <i>cruzi</i> infection. by Angela D. Pack (5954858)

    Published 2018
    “…<p>(A) The proportion of PD-1+ parasite-specific CD8<sup>+</sup> spleen and muscle derived cells decreases between acute (<40d) and chronic infection (>100d). …”
  16. 10956

    SB105-A10 treatment inhibits the HIV replication of HIV-1 reference strains and isolates from HIV-1 positive pateints. by Isabella Bon (467395)

    Published 2013
    “…<p>Different concentrations (0, 0.1, 1, 5, 10 and 20 µg/ml) of SB105-A10 were added to HIV-1 reference (<b>A</b>) and isolated (<b>B</b>) strains (100 pg/ml p24) for 1 hours at 37°C and then added to activated PBMCs. …”
  17. 10957

    Data_Sheet_1_Ramadan diurnal intermittent fasting is associated with significant plasma metabolomics changes in subjects with overweight and obesity: A prospective cohort study.xls... by Mohamed Madkour (4837197)

    Published 2023
    “…</p>Methods<p>Twenty-five metabolically healthy participants with overweight and obesity (7 females and 18 males, with a mean age of 39.48 ± 10.0 years) were recruited for the study and were followed before and at the end of RDIF month. …”
  18. 10958

    The effect of estrogen deprivation and estrogen treatment on the growth of BRCA1 antisense and control cells by Lois A Annab (54446)

    Published 2011
    “…</p><p>Copyright © This article is a work of the United States Government and as such must remain in the public domain</p> The mean cell number of BRCA1 pooled population antisense infected cells (filled circle) and vector-only infected cells (white circle) deprived of estrogen for up to 20 days after plating 2.5×10 cells per 100-mm dish. …”
  19. 10959

    Supplementary Figure 1 from Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma by Diana Cirstea (48960)

    Published 2023
    “…Transfected cells (IGF1R knock out cells) were cultured with and without AZD8055 100 nM. IGF1R knockout cells show 39% decrease in viability compared to scramble control and the combination of IGF1R knock out and AZD8055 100 nM show a 78% decrease in viability compared to scramble control. …”
  20. 10960

    Supplementary file 1_Soluble suppression of tumorigenicity-2 changes during cardiotoxic cancer treatment: a systematic review and meta-analysis.docx by Luca Fazzini (22599380)

    Published 2025
    “…</p>Results<p>Eight studies were included, comprising 433 patients treated with anthracycline and/or HER2-directed antibodies. There was a trend toward increased sST2 levels from T0 to T2 (MD 1.86, 95% CI −0.97 to 4.68, p = 0.200) and decreased levels from T1 to T2 (MD −1.96, 95% CI −4.28 to 0.37, p = 0.100). …”